Survival, Prostheses Clinical Trial
— EFeReOfficial title:
Evaluation of Partial and Total Femoral Replacement Treated in a Single Orthopedic Centre
Several surgical options for the reconstruction of massive bone defects have been described and include biologic methods with autografts and allografts, and the use of tumor endoprostheses (total femoral replacement, TFR). Several types of modular TFR are available, but nevertheless unpredictable outcomes and high complication rates have been described from most authors. The aim of the present study was to compare complication rates after TFR performed with modular total femur prosthesis MML (Fa. ESKA/Orthodynamics) in patients with and without malignant disease.
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | April 1, 2019 |
| Est. primary completion date | March 1, 2018 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years to 90 Years |
| Eligibility |
Inclusion Criteria: - Total or partial femoral replacement Exclusion Criteria: - Failure of device |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Klinikum rechts der Isar | Munich |
| Lead Sponsor | Collaborator |
|---|---|
| Technische Universität München |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Survival of device | Any device-related complications are defined failure | 2 years |